Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.

Touzart A, Boissel N, Belhocine M, Smith C, Graux C, Latiri M, Lhermitte L, Mathieu EL, Huguet F, Lamant L, Ferrier P, Ifrah N, Macintyre E, Dombret H, Asnafi V, Spicuglia S.

Haematologica. 2019 Sep 19. pii: haematol.2019.223677. doi: 10.3324/haematol.2019.223677. [Epub ahead of print]

2.

Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab.

Fradet M, Sibaud V, Tournier E, Lamant L, Boulinguez S, Brun A, Pages C, Meyer N.

Acta Derm Venereol. 2019 Aug 22. doi: 10.2340/00015555-3301. [Epub ahead of print] No abstract available.

3.

Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.

Fradet M, Negretto M, Tournier E, Laurent C, Apoil PA, Evrard S, Degboe Y, Del Mas V, Lamant L, Dubreuil P, Laroche M, Mailhol C, Hermine O, Paul C, Bulai Livideanu C.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1713-1718. doi: 10.1111/jdv.15638. Epub 2019 May 17.

PMID:
31009132
4.

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients.

Sibon D, Nguyen DP, Schmitz N, Suzuki R, Feldman AL, Gressin R, Lamant L, Weisenburger DD, Rosenwald A, Nakamura S, Ziepert M, Maurer MJ, Bast M, Armitage JO, Vose JM, Tilly H, Jais JP, Savage KJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.213512. doi: 10.3324/haematol.2018.213512. [Epub ahead of print]

5.

Staging of primary cutaneous follicle centre B-cell lymphoma: bone marrow biopsy, CD10, BCL2 and t(14;18) are not relevant prognostic factors.

Guinard E, Alenezi F, Lamant L, Szablewski V, Tournier E, Laurent C, Paul C, Meyer N, Dereure O, Boulinguez S.

Eur J Dermatol. 2019 Apr 17. doi: 10.1684/ejd.2018.3489. [Epub ahead of print]

PMID:
30998188
6.

A case of merkel leptomeningeal evolution after complete remission upon anti-PD-1 treatment.

Godeau M, Pages-Laurent C, Severino-Freire M, Guinard E, Tauber M, Larrieu-Ciron D, Lamant L, Evrard SM, Riffaud L, Sibaud V, Boulinguez S, Meyer N.

Eur J Cancer. 2019 May;113:55-57. doi: 10.1016/j.ejca.2019.03.009. Epub 2019 Apr 11. No abstract available.

PMID:
30981092
7.

[Mass of adipose tissue: Inflammation, pseudo-tumour and tumour: The cornelian fan: Case No. 1].

Lamant L, Le Guellec S.

Ann Pathol. 2019 Jun;39(3):188-191. doi: 10.1016/j.annpat.2019.02.003. Epub 2019 Feb 26. French. No abstract available.

PMID:
30824317
8.

[Mass of adipose tissue: Inflammation, pseudo-tumour and tumour: The cornelian fan: Introduction].

Macagno N, Karanian-Philippe M, Le Loarer F, Lamant L, Le Guellec S.

Ann Pathol. 2019 Jun;39(3):179-182. doi: 10.1016/j.annpat.2019.01.008. Epub 2019 Feb 26. French. No abstract available.

PMID:
30824314
9.

Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.

Menguy S, Beylot-Barry M, Parrens M, Ledard AP, Frison E, Comoz F, Battistella M, Szablewski V, Balme B, Croue A, Franck F, Ortonne N, Tournier E, Lamant L, Carlotti A, De Muret A, Le Gall F, Lorton MH, Merlio JP, Vergier B.

Histopathology. 2019 Jun;74(7):1067-1080. doi: 10.1111/his.13832. Epub 2019 Apr 25.

PMID:
30715765
10.

Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.

Torossian A, Broin N, Frentzel J, Daugrois C, Gandarillas S, Saati TA, Lamant L, Brousset P, Giuriato S, Espinos E.

Haematologica. 2019 Jul;104(7):1428-1439. doi: 10.3324/haematol.2017.181966. Epub 2019 Jan 24.

11.

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.

Hoareau-Aveilla C, Quelen C, Congras A, Caillet N, Labourdette D, Dozier C, Brousset P, Lamant L, Meggetto F.

Haematologica. 2019 Feb;104(2):347-359. doi: 10.3324/haematol.2018.195131. Epub 2018 Sep 27.

12.

Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?

Gaspard M, Lamant L, Tournier E, Valentin T, Rochaix P, Terrier P, Ranchere-Vince D, Coindre JM, Filleron T, Le Guellec S.

Histopathology. 2018 Dec;73(6):969-982. doi: 10.1111/his.13740. Epub 2018 Oct 23.

PMID:
30137667
13.

Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.

Lucas P, Boulinguez S, Sibaud V, Mourey L, Lamant L, Paul C, Meyer N.

Dermatology. 2018;234(3-4):92-98. doi: 10.1159/000490891. Epub 2018 Aug 15.

PMID:
30110681
14.

Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.

Casassa EA, Mailhol C, Tournier E, Laurent C, Degboe Y, Eischen M, Kirsten N, Moreau J, Evrard SM, Mansat-De Mas V, Lamant L, Dubreuil P, Apoil PA, Hermine O, Paul C, Bulai Livideanu C.

Allergol Int. 2019 Jan;68(1):119-121. doi: 10.1016/j.alit.2018.07.003. Epub 2018 Aug 7. No abstract available.

15.

[Dermatopathology histoseminar. Case 6].

Lamant L.

Ann Pathol. 2018 Aug;38(4):241-244. doi: 10.1016/j.annpat.2018.05.008. Epub 2018 Jul 3. Review. French. No abstract available.

PMID:
29980306
16.

[Dermatopathology histoseminar. Case 5].

Lamant L.

Ann Pathol. 2018 Aug;38(4):236-240. doi: 10.1016/j.annpat.2018.05.009. Epub 2018 Jul 3. Review. French. No abstract available.

PMID:
29980305
17.

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy.

Dupuis F, Lamant L, Gerard E, Torossian N, Chaltiel L, Filleron T, Beylot-Barry M, Dutriaux C, Prey S, Gros A, Jullie ML, Meyer N, Vergier B.

Br J Cancer. 2018 Jul;119(2):193-199. doi: 10.1038/s41416-018-0168-9. Epub 2018 Jul 5.

18.

[Dermatopathology histoseminar: Introduction].

Fraitag S, Lamant L.

Ann Pathol. 2018 Aug;38(4):207-209. doi: 10.1016/j.annpat.2018.05.003. Epub 2018 Jun 13. French. No abstract available.

PMID:
29908855
19.

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Russano de Paiva Silva G, Tournier E, Sarian LO, Bulai-Livideanu C, Delsol G, Lamant L, Vassallo J, Brousset P, Laurent C.

Medicine (Baltimore). 2018 May;97(21):e10642. doi: 10.1097/MD.0000000000010642.

20.

[Dermatologic toxicities of immune checkpoint inhibitors].

Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N.

Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Review. French.

PMID:
29678394
21.

Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge.

Perron E, Pissaloux D, Charon Barra C, Karanian M, Lamant L, Parfait S, Alberti L, de la Fouchardière A.

Am J Surg Pathol. 2018 May;42(5):595-603. doi: 10.1097/PAS.0000000000000973.

PMID:
29635259
22.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.

Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.

23.

Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum.

Salomon G, Maza A, Boulinguez S, Paul C, Lamant L, Tournier E, Mazereeuw-Hautier J, Meyer N.

Br J Dermatol. 2018 May;178(5):1199-1203. doi: 10.1111/bjd.16270. Epub 2018 Feb 26.

PMID:
29274233
24.

[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].

Casassa EA, Nicol P, Viraben R, Gaudin C, Bulai Livideanu C, Mengelle C, Lamant L, Fortenfant F, Paul C, Konstantinou MP.

Ann Dermatol Venereol. 2018 Mar;145(3):182-186. doi: 10.1016/j.annder.2017.10.013. Epub 2017 Dec 6. French.

PMID:
29221652
25.

Trichodysplasia spinulosa associated with HIV infection: clinical response to acitretin and valganciclovir.

Aleissa M, Konstantinou MP, Samimi M, Lamant L, Gaboriaud P, Touze A, Ceppi C, Bulai Livideanu C, Paul C.

Clin Exp Dermatol. 2018 Mar;43(2):231-233. doi: 10.1111/ced.13286. Epub 2017 Oct 13. No abstract available.

PMID:
29028114
26.

Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.

Le Guellec S, Macagno N, Velasco V, Lamant L, Lae M, Filleron T, Malissen N, Cassagnau E, Terrier P, Chevreau C, Ranchere-Vince D, Coindre JM.

Mod Pathol. 2017 Dec;30(12):1677-1687. doi: 10.1038/modpathol.2017.91. Epub 2017 Jul 28.

27.

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.

Morel A, Brière J, Lamant L, Loschi M, Haioun C, Delarue R, Tournilhac O, Bachy E, Sonet A, Amorim S, Laurent C, Gaulard P, Tilly H, Sibon D.

Eur J Cancer. 2017 Sep;83:146-153. doi: 10.1016/j.ejca.2017.06.026. Epub 2017 Jul 20.

PMID:
28735072
28.

Actinic keratosis modelling in mice: A translational study.

Pillon A, Gomes B, Vandenberghe I, Cartron V, Cèbe P, Blanchet JC, Sibaud V, Guilbaud N, Audoly L, Lamant L, Kruczynski A.

PLoS One. 2017 Jun 29;12(6):e0179991. doi: 10.1371/journal.pone.0179991. eCollection 2017.

29.

No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patients.

Masson Regnault M, Vigarios E, Projetti F, Herbault-Barres B, Tournier E, Lamant L, Sibaud V.

J Med Virol. 2017 Nov;89(11):2055-2057. doi: 10.1002/jmv.24887. Epub 2017 Jul 25.

PMID:
28661003
30.

[Drug eruption with clomifene citrate in a bodybuilder].

Severino-Freire M, Lamant L, Bagheri H, Mazereeuw-Hautier J, Paul C.

Ann Dermatol Venereol. 2017 Oct;144(10):636-637. doi: 10.1016/j.annder.2017.05.005. Epub 2017 Jun 20. French. No abstract available.

PMID:
28645464
31.

Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Negulescu M, Deilhes F, Sibaud V, Tournier E, Lamant L, Boulinguez S, Meyer N.

Case Rep Dermatol. 2017 Mar 21;9(1):80-85. doi: 10.1159/000461571. eCollection 2017 Jan-Apr.

32.

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.

Sibaud V, Eid C, Belum VR, Combemale P, Barres B, Lamant L, Mourey L, Gomez-Roca C, Estilo CL, Motzer R, Vigarios E, Lacouture ME.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e464-e469. doi: 10.1111/jdv.14284. Epub 2017 May 8. No abstract available.

33.

Systemic allergic contact dermatitis caused by methyl aminolaevulinate in a patient with keratosis-ichthyosis-deafness syndrome.

Al Malki A, Marguery MC, Giordano-Labadie F, Konstantinou MP, Mokeddem L, Lamant L, Paul C, Maza A, Mazereeuw-Hautier J.

Contact Dermatitis. 2017 Mar;76(3):190-192. doi: 10.1111/cod.12703. No abstract available.

PMID:
28220562
34.

Sclerosing sweat duct carcinoma of the penis in a 4-year-old child.

Abbo O, Gas J, Pinnagoda K, Tournier E, Bouali O, Castex MP, Lamant L, Galinier P.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26323. Epub 2016 Nov 1. No abstract available.

PMID:
27800657
35.

Photo-induced graft-versus-host disease.

Hardy JM, Marguery MC, Huynh A, Borel C, Apoil PA, Lamant L, Tournier E, Alberto C, Pauwels C, Thomas M, Mazereeuw Hautier J, Paul C, Bulai Livideanu C.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):291-295. doi: 10.1111/phpp.12273. Epub 2016 Oct 19.

PMID:
27623188
36.

Immunohistochemical staining for diagnosis of cutaneous mastocytosis.

Kirsten N, Tournier E, Lepage B, Lamant L, Hermine O, Paul C, Bulai Livideanu C.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e160-e162. doi: 10.1111/jdv.13946. Epub 2016 Sep 12. No abstract available.

PMID:
27558023
37.

Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.

Masson Regnault M, Ofaiche J, Boulinguez S, Tournier E, Rochaix P, Paul C, Lamant L, Meyer N.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e73-e74. doi: 10.1111/jdv.13733. Epub 2016 Jun 3. No abstract available.

PMID:
27256718
38.

MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.

Menguy S, Gros A, Pham-Ledard A, Battistella M, Ortonne N, Comoz F, Balme B, Szablewski V, Lamant L, Carlotti A, Lorton MH, de Muret A, Le Gall F, Franck F, Croue A, Cappellen D, Beylot-Barry M, Merlio JP, Vergier B.

J Invest Dermatol. 2016 Aug;136(8):1741-1744. doi: 10.1016/j.jid.2016.04.018. Epub 2016 May 14. No abstract available.

39.

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.

Sibaud V, Meyer N, Lamant L, Vigarios E, Mazieres J, Delord JP.

Curr Opin Oncol. 2016 Jul;28(4):254-63. doi: 10.1097/CCO.0000000000000290. Review.

PMID:
27136138
40.

Angiolymphoid hyperplasia with eosinophilia treated with low-dose methotrexate.

Alaidarous A, Bouissou X, Mazereeuw-Hautier J, Bulai-Livideanu C, Lamant L, Paul C.

JAAD Case Rep. 2015 Sep 27;1(6):342-4. doi: 10.1016/j.jdcr.2015.08.006. eCollection 2015 Nov. No abstract available.

41.

Anaplastic large cell lymphoma in paediatric and young adult patients.

Turner SD, Lamant L, Kenner L, Brugières L.

Br J Haematol. 2016 May;173(4):560-72. doi: 10.1111/bjh.13958. Epub 2016 Feb 23. Review.

PMID:
26913827
42.

Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.

Severino M, Chandesris MO, Barete S, Tournier E, Sans B, Laurent C, Apoil PA, Lamant L, Mailhol C, Laroche M, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C.

J Am Acad Dermatol. 2016 May;74(5):885-91.e1. doi: 10.1016/j.jaad.2015.10.050. Epub 2016 Feb 19.

PMID:
26899198
43.

Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.

Bulai Livideanu C, Apoil PA, Lepage B, Eischen M, Laurent C, Laharrague P, Lamant L, Tournier E, Tavitian S, Pouplard C, Recher C, Laroche M, Mailhol C, Dubreuil P, Hermine O, Blancher A, Paul C.

Clin Exp Allergy. 2016 Jan;46(1):133-41. doi: 10.1111/cea.12627.

PMID:
26767494
44.

Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.

Malcolm TI, Villarese P, Fairbairn CJ, Lamant L, Trinquand A, Hook CE, Burke GA, Brugières L, Hughes K, Payet D, Merkel O, Schiefer AI, Ashankyty I, Mian S, Wasik M, Turner M, Kenner L, Asnafi V, Macintyre E, Turner SD.

Nat Commun. 2016 Jan 12;7:10087. doi: 10.1038/ncomms10087.

45.

Highly Concordant Results Between Immunohistochemistry and Molecular Testing of Mutated V600E BRAF in Primary and Metastatic Melanoma.

Manfredi L, Meyer N, Tournier E, Grand D, Uro-Coste E, Rochaix P, Brousset P, Lamant L.

Acta Derm Venereol. 2016 Jun 15;96(5):630-4. doi: 10.2340/00015555-2326.

46.

Melanoma-expressed CD70 is involved in invasion and metastasis.

Pich C, Sarrabayrouse G, Teiti I, Mariamé B, Rochaix P, Lamant L, Favre G, Maisongrosse V, Tilkin-Mariamé AF.

Br J Cancer. 2016 Jan 12;114(1):63-70. doi: 10.1038/bjc.2015.412. Epub 2015 Dec 15.

47.

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, Traverse-Glehen A, Rousset T, Quintin-Roue I, Petrella T, Emile JF, Amara N, Rochaix P, Chenard-Neu MP, Tasei AM, Menet E, Chomarat H, Costes V, Andrac-Meyer L, Michiels JF, Chassagne-Clement C, de Leval L, Brousset P, Delsol G, Lamant L.

Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.

48.

Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.

Masson Regnault M, Gadaud N, Boulinguez S, Tournier E, Lamant L, Gladieff L, Roche H, Guenounou S, Recher C, Sibaud V.

Dermatology. 2015;231(4):312-8. doi: 10.1159/000439047. Epub 2015 Oct 1. Review.

PMID:
26422424
49.

Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.

Mitou G, Frentzel J, Desquesnes A, Le Gonidec S, AlSaati T, Beau I, Lamant L, Meggetto F, Espinos E, Codogno P, Brousset P, Giuriato S.

Oncotarget. 2015 Oct 6;6(30):30149-64. doi: 10.18632/oncotarget.4999.

50.

Acute skin reaction suggestive of pembrolizumab-induced radiosensitization.

Sibaud V, David I, Lamant L, Resseguier S, Radut R, Attal J, Meyer N, Delord JP.

Melanoma Res. 2015 Dec;25(6):555-8. doi: 10.1097/CMR.0000000000000191.

PMID:
26312439

Supplemental Content

Loading ...
Support Center